XNCR Q4 2021 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$890M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$154M+268.0% YoY

Gross Profit

$103M66.9% margin

Operating Income

$92M59.5% margin

Net Income

$73M47.4% margin

EPS (Diluted)

$1.21

QoQ Revenue Growth

+682.5%

Cash Flow

Operating Cash Flow

$62M

Free Cash Flow

$55M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$838M

Total Liabilities

$105M

Stockholders' Equity

$734M

Cash & Equivalents

$143M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$154M	$42M	+268.0%
Gross Profit	$103M	-$6M	+1790.4%
Operating Income	$92M	-$14M	+769.1%
Net Income	$73M	-$14M	+633.6%

Revenue Segments

Royalties

$53M72%

Research collaboration

$13M18%

Milestone

$7M10%